Wall Street analyst estimates for SOPHiA GENETICS S.A. (SOPH): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe.
Valuation Ratios
| Price / Book | 7.33 |
| EV / EBITDA | -9.10 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $25.4M | $28.4M | $40.5M | $47.6M | $62.4M | $65.2M | $77.3M |
| Cost of Revenue | $7.5M | $10.7M | $15.2M | $16.3M | $19.5M | $21.2M | $29.5M |
| Gross Profit | $17.8M | $17.7M | $25.2M | $31.3M | $42.9M | $43.9M | $47.8M |
| Research & Development | $15.0M | $18.6M | $26.6M | $35.4M | $37.0M | $34.4M | $33.6M |
| Selling, General & Admin | $35.1M | $36.4M | $70.2M | $84.1M | $81.7M | $76.3M | $85.2M |
| Operating Expenses | $50.1M | $55.1M | $96.7M | $119.1M | $117.7M | $110.5M | $118.7M |
| Operating Income | -$32.3M | -$37.4M | -$71.5M | -$87.8M | -$74.8M | -$66.6M | -$70.9M |
| EBITDA | -$30.7M | -$38.0M | -$69.2M | -$81.4M | -$69.6M | -$50.8M | -$64.4M |
| Interest Expense | $976000 | $840000 | $658000 | $639000 | $588000 | $1.9M | $4.6M |
| Pre-tax Income | -$33.6M | -$41.2M | -$73.5M | -$87.6M | -$78.5M | -$61.3M | -$78.5M |
| Income Tax | $162000 | -$1.9M | $168000 | -$136000 | $486000 | $1.2M | $512000 |
| Net Income | -$33.8M | -$39.3M | -$73.7M | -$87.4M | -$79.0M | -$62.5M | -$79.0M |
| EPS | $-0.53 | $-0.82 | $-1.33 | $-1.36 | $-1.22 | $-0.95 | $-1.17 |
| EPS (Diluted) | $-0.53 | $-0.82 | $-1.33 | $-1.36 | $-1.22 | $-0.95 | $-1.17 |
| Shares Outstanding (Diluted) | $63.9M | $48.0M | $55.3M | $64.1M | $64.8M | $65.8M | $67.5M |
Price
| Price | $7.97 |
| Market Cap | $669M |
| Exchange | NASDAQ |
| Country | CH |
Related companies: ACIU · AGL · ANRO · CLLS · DH · LRMR · NAKA
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of SOPH: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks